Celtaxsys is a privately-held drug discovery and development company focused on advancing treatments for serious inflammatory diseases. The company is building a sustainable pipeline of first-in-class immuno-modulators, the most advanced of which is CTX-4430.
Market
Pharmaceuticals
Location
Atlanta,
GA,
USA
Coinvestors
Domain Associates, Georgia Research Alliance, Lumira Capital, Masters Capital Management, RusnanoMedInvest